The new sensor — expected to launch in the second half of 2025 — will provide easier diabetes management for eligible users.

Dexcom has won a clearance from the FDA for its longest-lasting continuous glucose monitor, a 15-day version of its flagship ...

研究结果主要包括以下几个方面： 数据描述：研究共纳入 108 名 1 型糖尿病年轻成人，收集了超过 118,000 天的 CGM 数据，包含 2298 万余个血糖样本。参与者年龄在 19 - 29 岁之间，平均病程 11.5 年，多数人使用 Dexcom CGM 联合胰岛素泵或多次注射胰岛素治疗。数据 ...

The Dexcom G7 15 Day CGM system is a wearable sensor that continuously measures glucose levels and transmits readings every 5 minutes with no fingersticks or scanning required.

Global sensation Nick Jonas has always been open about his health journey, and recently, the singer reflected on being ...

We anticipate Dexcom can continue to offer new features, such as lengthening sensor life, shrinking the size and profile of the CGM, making the insertion less painful, and improving accuracy.

San Diego-based Dexcom submitted its 15-day G7 CGM to the FDA in October 2024. The company says its 15-day G7 also meets ...

DexCom, Inc. (NASDAQ:DXCM), the global leader in glucose biosensing, announced today the FDA has cleared the Dexcom G7 15 Day ...

It's the longest-lasting wearable on the market. The G7 15-day sensor builds on the technology and performance of the Dexcom G7 CGM, which has proven to lower A1C and reduce hyper- and hypoglycemia.

Medtronic plc’s diabetes unit posted another win with the U.S. FDA approval of the Simplera continuous glucose monitoring sensor for use with the Minimed 780G pump system, helping the company catch up ...

executive vice president and chief operating officer at Dexcom. “By listening to the needs of our users, we’re proud to offer the longest lasting wearable and most accurate CGM, giving people ...